Nikolay Plotnikov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nikolay Plotnikov has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Rakitko
National Research University Higher School of Economics, Russian Federation, Moscow, Russia
6 shared publications - Anna Kim
Genotek Ltd
5 shared publications - Ekaterina Vergasova
Genotek Ltd
5 shared publications - Elena V. Kovalenko
Genotek Ltd
5 shared publications - Valery Vladimirovich Ilinsky
Bekhterev National Medical Research Center for Psychiatry and Neurology
5 shared publications - Anna Ilinskaya
Genotek Ltd., Moscow, Russia
4 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Problems of Nutrition
- Vol. 94 (2) , 38-51
Genetics of lactase deficiency in Russia
Генетика лактазной недостаточности в России
- 1 January 2025
- Published by Geotar-Media Publishing Group in Problems of Nutrition
- Vol. 94 (2) , 38-51
Open AccessGenetics of lactase deficiency in Russia
Генетика лактазной недостаточности в России
- Open Access
- 6 July 2024
- Published by ECO-Vector LLC in Consortium Psychiatricum
- Vol. 5 (2) , 5-15
Genetic Associations of Anhedonia: Insights into Overlap of Mental and Somatic Disorders
BACKGROUND: Anhedonia is characterized by a reduced ability to anticipate, experience, and/or learn about pleasure. This phenomenon has a transdiagnostic nature and is one of the key symptoms of mood disorders, schizophrenia, addictions, and somatic conditions. AIM: To evaluate the genetic architecture of anhedonia and its overlap with other mental disorders and somatic conditions. METHODS: We performed a genome-wide association study of anhedonia on a sample of 4,520 individuals from a Russian non-clinical population. Using the available summary statistics, we calculated polygenic risk scores (PRS) to investigate the genetic relationship between anhedonia and other psychiatric or somatic phenotypes. RESULTS: No variants with a genome-wide significant association were identified. PRS for major depression, bipolar disorder, and schizophrenia were significantly associated with anhedonia. Conversely, no significant associations were found between PRS for anxiety and anhedonia, which aligns well with existing clinical evidence. None of the PRS for somatic phenotypes attained a significance level after correction for multiple comparisons. A nominal significance for the anhedonia association was determined for omega-3 fatty acids, type 2 diabetes mellitus, and Crohn’s disease. CONCLUSION: Anhedonia has a complex polygenic architecture, and its presence in somatic diseases or normal conditions may be due to a genetic predisposition to mood disorders or schizophrenia.
- 6 July 2024
- Published by ECO-Vector LLC in Consortium Psychiatricum
- Vol. 5 (2) , 5-15
Open AccessGenetic Associations of Anhedonia: Insights into Overlap of Mental and Somatic Disorders
BACKGROUND: Anhedonia is characterized by a reduced ability to anticipate, experience, and/or learn about pleasure. This phenomenon has a transdiagnostic nature and is one of the key symptoms of mood disorders, schizophrenia, addictions, and somatic conditions. AIM: To evaluate the genetic architecture of anhedonia and its overlap with other mental disorders and somatic conditions. METHODS: We performed a genome-wide association study of anhedonia on a sample of 4,520 individuals from a Russian non-clinical population. Using the available summary statistics, we calculated polygenic risk scores (PRS) to investigate the genetic relationship between anhedonia and other psychiatric or somatic phenotypes. RESULTS: No variants with a genome-wide significant association were identified. PRS for major depression, bipolar disorder, and schizophrenia were significantly associated with anhedonia. Conversely, no significant associations were found between PRS for anxiety and anhedonia, which aligns well with existing clinical evidence. None of the PRS for somatic phenotypes attained a significance level after correction for multiple comparisons. A nominal significance for the anhedonia association was determined for omega-3 fatty acids, type 2 diabetes mellitus, and Crohn’s disease. CONCLUSION: Anhedonia has a complex polygenic architecture, and its presence in somatic diseases or normal conditions may be due to a genetic predisposition to mood disorders or schizophrenia.
- 27 January 2024
- Published by Springer Nature in Polar Biology
- Vol. 47 (3) , 209-226
Free-living bacterial diversity in the Kara and Laptev seas: spatial variability and environmental control
- 27 January 2024
- Published by Springer Nature in Polar Biology
- Vol. 47 (3) , 209-226
Free-living bacterial diversity in the Kara and Laptev seas: spatial variability and environmental control
- 13 June 2023
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 77 (8) , 803-810
Lactase deficiency in Russia: multiethnic genetic study
Background Lactase persistence—the ability to digest lactose through adulthood—is closely related to evolutionary adaptations and has affected many populations since the beginning of cattle breeding. Nevertheless, the contrast initial phenotype, lactase non-persistence or adult lactase deficiency, is still observed in large numbers of people worldwide. Methods We performed a multiethnic genetic study of lactase deficiency on 24,439 people, the largest in Russia to date. The percent of each population group was estimated according to the local ancestry inference results. Additionally, we calculated frequencies of rs4988235 GG genotype in Russian regions using the information of current location and birthplace data from the client’s questionnaire. Results The attained results show that among all studied population groups, the frequency of GG genotype in rs4988235 is higher than the average in the European populations. In particular, the prevalence of lactase deficiency genotype in the East Slavs group was 42.8% (95% CI: 42.1–43.4%). We also investigated the regional prevalence of lactase deficiency based on the current place of residence. Conclusions Our study emphasizes the significance of genetic testing for diagnostics, i.e., specifically for lactose intolerance parameter, as well as the scale of the problem of lactase deficiency in Russia which needs to be addressed by the healthcare and food sectors.
- 13 June 2023
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 77 (8) , 803-810
Lactase deficiency in Russia: multiethnic genetic study
Background Lactase persistence—the ability to digest lactose through adulthood—is closely related to evolutionary adaptations and has affected many populations since the beginning of cattle breeding. Nevertheless, the contrast initial phenotype, lactase non-persistence or adult lactase deficiency, is still observed in large numbers of people worldwide. Methods We performed a multiethnic genetic study of lactase deficiency on 24,439 people, the largest in Russia to date. The percent of each population group was estimated according to the local ancestry inference results. Additionally, we calculated frequencies of rs4988235 GG genotype in Russian regions using the information of current location and birthplace data from the client’s questionnaire. Results The attained results show that among all studied population groups, the frequency of GG genotype in rs4988235 is higher than the average in the European populations. In particular, the prevalence of lactase deficiency genotype in the East Slavs group was 42.8% (95% CI: 42.1–43.4%). We also investigated the regional prevalence of lactase deficiency based on the current place of residence. Conclusions Our study emphasizes the significance of genetic testing for diagnostics, i.e., specifically for lactose intolerance parameter, as well as the scale of the problem of lactase deficiency in Russia which needs to be addressed by the healthcare and food sectors.
- 4 May 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (4) , 65-73
Anhedonia in mood disorders and somatic diseases: results of exploratory Mendelian randomization analysis
ЦЕЛЬ ИССЛЕДОВАНИЯ Провести разведочный Менделевский рандомизационный анализ причинных связей ангедонии с широким кругом психиатрических и соматических фенотипов на основе генетических данных участников популяционного исследования. МАТЕРИАЛ И МЕТОДЫ Данное кросс-секционное исследование включало 4520 участников, из которых 50,4% (n=2280) были женского пола. Средний возраст составил 36,8 (S.D.=9,8) года. Фенотипирование участников проводилось на основании критериев DSM-5 для ангедонии в рамках депрессивного расстройства. Об эпизоде ангедонии, превышающем 2 нед, в течение жизни сообщили 57,6% (n=2604) участников. Был проведен полногеномный ассоциативный анализ (genome-wide association study, GWAS) фенотипа ангедонии, а также Менделевский рандомизационный анализ с использованием сводных статистик крупномасштабных GWAS по психиатрическим и соматическим фенотипам. РЕЗУЛЬТАТЫ По итогу GWAS ангедонии не было выявлено ни одного варианта, достигшего геномного уровня значимости. Наиболее значимым (P=9,71×10–7) был вариант rs296009 (chr5:168513184). Данный однонуклеотидный полиморфизм находится в интроне гена SLIT 3 (лиганд наведения slit 3). С помощью Менделевской рандомизации были выявлены номинально значимые (pp=0,0004, OR=0,9986, 95% ДИ 0,9978—0,999)), минимального фенотипа депрессии (p=0,009, OR=1,004, 95% ДИ 1,001—1,007), а также для аполипопротеина A (p=0,01, OR=0,973, 95% ДИ 0,952—0,993) и заболеваний дыхательной системы (p=0,01, OR=0,9988, 95% ДИ 0,9980—0,9997). ЗАКЛЮЧЕНИЕ Полигенная природа ангедонии может обусловливать риски коморбидности данного фенотипа с широким кругом соматических заболеваний, а также иметь связь с расстройствами настроения.
- 4 May 2023
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 123 (4) , 65-73
Anhedonia in mood disorders and somatic diseases: results of exploratory Mendelian randomization analysis
ЦЕЛЬ ИССЛЕДОВАНИЯ Провести разведочный Менделевский рандомизационный анализ причинных связей ангедонии с широким кругом психиатрических и соматических фенотипов на основе генетических данных участников популяционного исследования. МАТЕРИАЛ И МЕТОДЫ Данное кросс-секционное исследование включало 4520 участников, из которых 50,4% (n=2280) были женского пола. Средний возраст составил 36,8 (S.D.=9,8) года. Фенотипирование участников проводилось на основании критериев DSM-5 для ангедонии в рамках депрессивного расстройства. Об эпизоде ангедонии, превышающем 2 нед, в течение жизни сообщили 57,6% (n=2604) участников. Был проведен полногеномный ассоциативный анализ (genome-wide association study, GWAS) фенотипа ангедонии, а также Менделевский рандомизационный анализ с использованием сводных статистик крупномасштабных GWAS по психиатрическим и соматическим фенотипам. РЕЗУЛЬТАТЫ По итогу GWAS ангедонии не было выявлено ни одного варианта, достигшего геномного уровня значимости. Наиболее значимым (P=9,71×10–7) был вариант rs296009 (chr5:168513184). Данный однонуклеотидный полиморфизм находится в интроне гена SLIT 3 (лиганд наведения slit 3). С помощью Менделевской рандомизации были выявлены номинально значимые (pp=0,0004, OR=0,9986, 95% ДИ 0,9978—0,999)), минимального фенотипа депрессии (p=0,009, OR=1,004, 95% ДИ 1,001—1,007), а также для аполипопротеина A (p=0,01, OR=0,973, 95% ДИ 0,952—0,993) и заболеваний дыхательной системы (p=0,01, OR=0,9988, 95% ДИ 0,9980—0,9997). ЗАКЛЮЧЕНИЕ Полигенная природа ангедонии может обусловливать риски коморбидности данного фенотипа с широким кругом соматических заболеваний, а также иметь связь с расстройствами настроения.
- 23 January 2023
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 77 (5) , 574-578
Association of common genetic variants with body mass index in Russian population
Background Overweight is the scourge of modern society and a major risk factor for many diseases. For this reason, understanding the genetic component predisposing to high body mass index (BMI) seems to be an important task along with preventive measures aimed at improving eating behavior and increasing physical activity. Methods We analyzed genetic data of a European cohort (n = 21,080, 47.25% women, East Slavs ancestry >80%) for 5 frequently found genes in the context of association with obesity: IPX3 (rs3751723), MC4R (rs17782313), TMEM18 (rs6548238), PPARG (rs1801282) and FTO (rs9939609). Results Our study revealed significant associations of FTO (rs9939609) (β = 0.37 (kg/m2)/allele, p = −16), MC4R (rs17782313) (β = 0.28 (kg/m2)/allele, p = 5.79 × 10−9), TMEM18 (rs6548238) (β = 0.29 (kg/m2)/allele, p = 2.43 × 10−8) with BMI and risk of obesity. Conclusions The results confirm the contribution of FTO, M4CR, and TMEM18 genes to the mechanism of body weight regulation and control.
- 23 January 2023
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 77 (5) , 574-578
Association of common genetic variants with body mass index in Russian population
Background Overweight is the scourge of modern society and a major risk factor for many diseases. For this reason, understanding the genetic component predisposing to high body mass index (BMI) seems to be an important task along with preventive measures aimed at improving eating behavior and increasing physical activity. Methods We analyzed genetic data of a European cohort (n = 21,080, 47.25% women, East Slavs ancestry >80%) for 5 frequently found genes in the context of association with obesity: IPX3 (rs3751723), MC4R (rs17782313), TMEM18 (rs6548238), PPARG (rs1801282) and FTO (rs9939609). Results Our study revealed significant associations of FTO (rs9939609) (β = 0.37 (kg/m2)/allele, p = −16), MC4R (rs17782313) (β = 0.28 (kg/m2)/allele, p = 5.79 × 10−9), TMEM18 (rs6548238) (β = 0.29 (kg/m2)/allele, p = 2.43 × 10−8) with BMI and risk of obesity. Conclusions The results confirm the contribution of FTO, M4CR, and TMEM18 genes to the mechanism of body weight regulation and control.
- Open Access
- 25 December 2022
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 50 (12)
Novel mutation in the MPZ gene causes early-onset but slow-progressive Charcot–Marie–Tooth disease in a Russian family: a case report
Charcot–Marie–Tooth disease (CMT) is a genetically heterogeneous group of peripheral neuropathies most of which are associated with mutations in four genes including peripheral myelin protein-22 ( PMP22), myelin protein zero ( MPZ), gap junction protein beta1 ( GJB1) and mitofusin2 ( MFN2). This current case report describes the clinical and genetic characteristics of a 6-year-old male proband. A physical examination revealed muscular hypotonia. He started walking on his own at 18 months. A nerve conduction study with needle electromyography revealed conduction block. A novel MPZ mutation (c.398C > T, p.Pro133Leu) was revealed in the proband. This mutation was also found in the 32-year-old father of the proband. The father had had deformity of the feet and distal muscle weakness since childhood. The novel p.Pro133Leu pathogenic mutation was responsible for early onset but slowly progressive CMT1B. We assume that this site is an intolerant to change region in the MPZ gene. This variant in the MPZ gene is an important contributor to hereditary neuropathy with reduced nerve conduction velocity in the Russian population. This case highlights the importance of whole exome sequencing for a proper clinical diagnosis of CMT associated with a mutation in the MPZ gene.
- 25 December 2022
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 50 (12)
Open AccessNovel mutation in the MPZ gene causes early-onset but slow-progressive Charcot–Marie–Tooth disease in a Russian family: a case report
Charcot–Marie–Tooth disease (CMT) is a genetically heterogeneous group of peripheral neuropathies most of which are associated with mutations in four genes including peripheral myelin protein-22 ( PMP22), myelin protein zero ( MPZ), gap junction protein beta1 ( GJB1) and mitofusin2 ( MFN2). This current case report describes the clinical and genetic characteristics of a 6-year-old male proband. A physical examination revealed muscular hypotonia. He started walking on his own at 18 months. A nerve conduction study with needle electromyography revealed conduction block. A novel MPZ mutation (c.398C > T, p.Pro133Leu) was revealed in the proband. This mutation was also found in the 32-year-old father of the proband. The father had had deformity of the feet and distal muscle weakness since childhood. The novel p.Pro133Leu pathogenic mutation was responsible for early onset but slowly progressive CMT1B. We assume that this site is an intolerant to change region in the MPZ gene. This variant in the MPZ gene is an important contributor to hereditary neuropathy with reduced nerve conduction velocity in the Russian population. This case highlights the importance of whole exome sequencing for a proper clinical diagnosis of CMT associated with a mutation in the MPZ gene.
- Open Access
- 31 October 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (21) , 11851
Induction of Premature Cell Senescence Stimulated by High Doses of Antioxidants Is Mediated by Endoplasmic Reticulum Stress
In our previous study, we found that high doses of several substances with antioxidant capacities (Tempol, resveratrol, diphenyleneiodonium) can cause genotoxic stress and induce premature senescence in the human mesenchymal stem cells (MSCs). Here, using whole-transcriptome analysis, we revealed the signs of endoplasmic reticulum stress and unfolded protein response (UPR) in MSCs stressed with Tempol and resveratrol. In addition, we found the upregulation of genes, coding the UPR downstream target APC/C, and E3 ubiquitin ligase that regulate the stability of cell cycle proteins. We performed the molecular analysis, which further confirmed the untimely degradation of APC/C targets (cyclin A, geminin, and Emi1) in MSCs treated with antioxidants. Human fibroblasts responded to antioxidant applications similarly. We conclude that endoplasmic reticulum stress and impaired DNA synthesis regulation can be considered as potential triggers of cell damage and premature senescence stimulated by high-dose antioxidant treatments.
- 31 October 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (21) , 11851
Open AccessInduction of Premature Cell Senescence Stimulated by High Doses of Antioxidants Is Mediated by Endoplasmic Reticulum Stress
In our previous study, we found that high doses of several substances with antioxidant capacities (Tempol, resveratrol, diphenyleneiodonium) can cause genotoxic stress and induce premature senescence in the human mesenchymal stem cells (MSCs). Here, using whole-transcriptome analysis, we revealed the signs of endoplasmic reticulum stress and unfolded protein response (UPR) in MSCs stressed with Tempol and resveratrol. In addition, we found the upregulation of genes, coding the UPR downstream target APC/C, and E3 ubiquitin ligase that regulate the stability of cell cycle proteins. We performed the molecular analysis, which further confirmed the untimely degradation of APC/C targets (cyclin A, geminin, and Emi1) in MSCs treated with antioxidants. Human fibroblasts responded to antioxidant applications similarly. We conclude that endoplasmic reticulum stress and impaired DNA synthesis regulation can be considered as potential triggers of cell damage and premature senescence stimulated by high-dose antioxidant treatments.
- Open Access
- 21 October 2020
- Published by Springer Nature in BMC Medical Genetics
- Vol. 21 (1) , 1-7
Two novel PCDH19 mutations in Russian patients with epilepsy with intellectual disability limited to females: a case report
Background: Epilepsy with intellectual disability limited to females (Epileptic encephalopathy, early infantile, 9; EIEE9) is a rare early infantile epileptic encephalopathy characterized by an unusual X-linked inheritance: females with heterozygous mutations are affected, while hemizygous males are not. Case presentation: We describe the clinical and molecular characteristics of 2 Russian patients with EIEE9 (females, ages 3 years and 7 years). In these patients seizures developed at the age of 3 years. Additionally, for our patients and for cases described in the literature we searched for a possible relationship between the type and localization of the mutation and the EIEE9 clinical phenotype. Conclusions: We identified two novel PCDH19 mutations in EIEE9 patients: a missense mutation in exon 1 (c.1236C > A, p.Asp412Glu) and a frameshift in exon 3 (c.2386_2387insGTCT, p.Thr796fs). We conclude that the age of seizure onset and the presence of intellectual disability may depend not on the type and localization of PCDH19 mutations, but on the X-inactivation status. The study also highlights the need to screen for EIEE9 among young female epilepsy patients.
- 21 October 2020
- Published by Springer Nature in BMC Medical Genetics
- Vol. 21 (1) , 1-7
Open AccessTwo novel PCDH19 mutations in Russian patients with epilepsy with intellectual disability limited to females: a case report
Background: Epilepsy with intellectual disability limited to females (Epileptic encephalopathy, early infantile, 9; EIEE9) is a rare early infantile epileptic encephalopathy characterized by an unusual X-linked inheritance: females with heterozygous mutations are affected, while hemizygous males are not. Case presentation: We describe the clinical and molecular characteristics of 2 Russian patients with EIEE9 (females, ages 3 years and 7 years). In these patients seizures developed at the age of 3 years. Additionally, for our patients and for cases described in the literature we searched for a possible relationship between the type and localization of the mutation and the EIEE9 clinical phenotype. Conclusions: We identified two novel PCDH19 mutations in EIEE9 patients: a missense mutation in exon 1 (c.1236C > A, p.Asp412Glu) and a frameshift in exon 3 (c.2386_2387insGTCT, p.Thr796fs). We conclude that the age of seizure onset and the presence of intellectual disability may depend not on the type and localization of PCDH19 mutations, but on the X-inactivation status. The study also highlights the need to screen for EIEE9 among young female epilepsy patients.